Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses…
M Allaire, M Rudler, D Thabut - Liver International, 2021 - Wiley Online Library
Abstract Background and Aims Portal hypertension (PHT) and hepatocellular carcinoma
(HCC) are major complication of cirrhosis which significantly contribute to morbidity and …
(HCC) are major complication of cirrhosis which significantly contribute to morbidity and …
Current strategies to identify patients that will benefit from TACE treatment and future directions a practical step-by-step guide
L Müller, F Stoehr, A Mähringer-Kunz… - Journal of …, 2021 - Taylor & Francis
Abstract Treatment of hepatocellular carcinoma (HCC) depends on the stage of disease. In
the Western Hemisphere, the Barcelona Clinic Liver Cancer classification (BCLC) is the …
the Western Hemisphere, the Barcelona Clinic Liver Cancer classification (BCLC) is the …
[HTML][HTML] Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
Objectives Splenic volume (SV) was proposed as a relevant prognostic factor for patients
with hepatocellular carcinoma (HCC). We trained a deep-learning algorithm to fully …
with hepatocellular carcinoma (HCC). We trained a deep-learning algorithm to fully …
Portal hypertension and variceal bleeding in patients with liver cancer: evidence gaps for prevention and management
M Allaire, D Thabut - Hepatology, 2024 - journals.lww.com
Results: Recent therapeutic advances observed in the management of HCC, notably
through the advent of immunotherapy, have led to a clear improvement in the survival of …
through the advent of immunotherapy, have led to a clear improvement in the survival of …
[HTML][HTML] TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension
Z Qiu, G Wang, H Yan, H Qi, M Zuo, G Wang… - European …, 2022 - Springer
Objectives Portal vein tumour thrombus (PVTT)–related symptomatic portal hypertension
(SPH) leads to a poor prognosis in hepatocellular carcinoma (HCC) patients. A transjugular …
(SPH) leads to a poor prognosis in hepatocellular carcinoma (HCC) patients. A transjugular …
[HTML][HTML] Baseline splenic volume outweighs immuno-modulated size changes with regard to survival outcome in patients with hepatocellular carcinoma under …
Simple Summary Splenic volume (SV) has been identified as a highly predictive parameter
for prognosis in patients with hepatocellular carcinoma (HCC). Moreover, an association …
for prognosis in patients with hepatocellular carcinoma (HCC). Moreover, an association …
Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child …
IJ Lee, JH Lee, YB Lee, YJ Kim… - Therapeutic …, 2019 - journals.sagepub.com
Background: This study aimed to compare the therapeutic effectiveness including
progression-free survival (PFS), overall survival (OS), and safety of conventional …
progression-free survival (PFS), overall survival (OS), and safety of conventional …
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
L Müller, F Hahn, A Mähringer‐Kunz… - United European …, 2022 - Wiley Online Library
Background Clinically evident portal hypertension (CEPH) was previously identified as a
prognostic factor for patients with hepatocellular carcinoma (HCC). However, little is known …
prognostic factor for patients with hepatocellular carcinoma (HCC). However, little is known …
A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
J Ni, Z Fang, H Sun, C An, Z Huang, T Zhang… - European …, 2020 - Springer
Objectives To develop a prognostic nomogram based on the albumin–bilirubin (ALBI) grade
for prediction of the long-term survival of patients with intermediate-stage hepatocellular …
for prediction of the long-term survival of patients with intermediate-stage hepatocellular …
[HTML][HTML] Antitumor effects of intra-arterial delivery of albumin-doxorubicin nanoparticle conjugated microbubbles combined with ultrasound-targeted microbubble …
Image-guided intra-arterial therapies play a key role in the management of hepatic
malignancies. However, limited clinical outcomes suggest the need for new multifunctional …
malignancies. However, limited clinical outcomes suggest the need for new multifunctional …